| European S3-guidelines on the systemic treatment of psoriasis vulgaris D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, ... Journal of the European Academy of Dermatology and Venereology 23 (SUPPL. 2 …, 2009 | 958 | 2009 |
| European S3-guidelines on the systemic treatment of psoriasis vulgaris-update 2015-short version-EDF in cooperation with EADV and IPC A Nast, P Gisondi, AD Ormerod, P Saiag, CH Smith, PI Spuls, ... Journal of the European Academy of Dermatology and Venereology 29 (12), 2277 …, 2015 | 533 | 2015 |
| Resurgence of Lymphogranuloma Venereum in Western Europe: An Outbreak of Chlamydia trachomatis Serovar L2 Proctitis in The Netherlands among Men Who … RF Nieuwenhuis, JM Ossewaarde, HM Götz, J Dees, HB Thio, ... Clinical infectious diseases 39 (7), 996-1003, 2004 | 409 | 2004 |
| Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum S Kezic, PMJH Kemperman, ES Koster, CM de Jongh, HB Thio, ... The Journal of investigative dermatology 128 (8), 2117-2119, 2008 | 388 | 2008 |
| Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients M Wakkee, HB Thio, EP Prens, EJG Sijbrands, HAM Neumann Atherosclerosis 190 (1), 1-9, 2007 | 375 | 2007 |
| A cluster of acute hepatitis C virus infection among men who have sex with men–results from contact tracing and public health implications HM Götz, G van Doornum, HGM Niesters, JG den Hollander, HB Thio, ... Aids 19 (9), 969-974, 2005 | 323 | 2005 |
| Chronic inflammation in psoriasis and obesity: implications for therapy EA Hamminga, AJ van der Lely, HAM Neumann, HB Thio Medical hypotheses 67 (4), 768-773, 2006 | 268 | 2006 |
| Long‐term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis JJ Hoefnagel, HB Thio, R Willemze, JN Bouwes Bavinck British Journal of Dermatology 149 (2), 363-369, 2003 | 218 | 2003 |
| Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa H Eppinga, CJ Sperna Weiland, HB Thio, CJ van der Woude, TEC Nijsten, ... Journal of Crohn's and Colitis 10 (9), 1067-1075, 2016 | 182 | 2016 |
| Pharmacokinetics of oral fumarates in healthy subjects NHR Litjens, J Burggraaf, E Van Strijen, C Van Gulpen, H Mattie, ... British journal of clinical pharmacology 58 (4), 429-432, 2004 | 173 | 2004 |
| Skin manifestations of diabetes S Van Hattem, AH Bootsma, HB Thio Cleve Clin J Med 75 (11), 772-774, 2008 | 170 | 2008 |
| European S3-Guideline on the systemic treatment of psoriasis vulgaris-Update Apremilast and Secukinumab-EDF in cooperation with EADV and IPC. A Nast, PI Spuls, G Van der Kraaij, P Gisondi, C Paul, AD Ormerod, ... Journal of the European Academy of Dermatology and Venereology: JEADV 31 (12 …, 2017 | 143 | 2017 |
| The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double‐blind, randomized, placebo‐controlled trial EMM Kuiper, KJ van Erpecum, U Beuers, BE Hansen, HB Thio, ... Hepatology 52 (4), 1334-1340, 2010 | 140 | 2010 |
| Psoriasis and microbiota: a systematic review F Benhadou, D Mintoff, B Schnebert, HB Thio Diseases 6 (2), 47, 2018 | 135 | 2018 |
| Lymphogranuloma venereum among men who have sex with men—Netherlands, 2003–2004 MJW Van de Laar, HM Götz, O de Zwart, W van der Meijden, ... MMWR Morb Mortal Wkly Rep 53 (42), 985-8, 2004 | 124 | 2004 |
| In vitro pharmacokinetics of anti-psoriatic fumaric acid esters NHR Litjens, E Van Strijen, C van Gulpen, H Mattie, JT van Dissel, ... BMC pharmacology 4, 1-7, 2004 | 108 | 2004 |
| Human IgE+ B cells are derived from T cell–dependent and T cell–independent pathways MA Berkowska, JJ Heeringa, E Hajdarbegovic, M Van Der Burg, HB Thio, ... Journal of allergy and clinical immunology 134 (3), 688-697. e6, 2014 | 105 | 2014 |
| E‐health in caring for patients with atopic dermatitis: a randomized controlled cost‐effectiveness study of internet‐guided monitoring and online self‐management training H van Os‐Medendorp, H Koffijberg, PCM Eland‐de Kok, A Van der Zalm, ... British Journal of Dermatology 166 (5), 1060-1068, 2012 | 105 | 2012 |
| Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa EM Baerveldt, JH Kappen, HB Thio, JAM van Laar, PM Van Hagen, ... Annals of the Rheumatic Diseases 72 (4), 626-627, 2013 | 98 | 2013 |
| IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe … DMW Balak, MBA van Doorn, RD Arbeit, R Rijneveld, E Klaassen, ... Clinical Immunology 174, 63-72, 2017 | 96 | 2017 |
